The comparison of interleukin 6-associated immunosuppressive effects of human ESCs, fetal-type MSCs, and adult-type MSCs

Transplantation

Volumn 94, Issue 2, 2012, Pages 132-138

  Chan, Chin Kan ^a,b   Wu, Kang Hsi ^c,d   Lee, Yun Shen ^e,f   Hwang, Shiaw Min ^g   Lee, Maw Sheng ^h,i   Liao, Shuen Kuei ^a,j   Cheng, En Hui ^k   See, Lai Chu ^a,h   Tsai, Chi Neu ^a   Kuo, Ming Ling ^a,l   Huang, Jing Long ^a,l  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e MING CHUAN UNIVERSITY   (Taiwan)

^f Genomic Medicine Research Core Laboratory   (Taiwan)

^g Development Institute   (Taiwan)

^h CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

ⁱ CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^j TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^k TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^l CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

more..

Author keywords

Embryonic stem cells; Immunosuppressive effects; Interleukin 6; Mesenchymal stem cells

Indexed keywords

INTERLEUKIN 6;

ADULT; ADULT STEM CELL; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DNA MICROARRAY; EMBRYO; EMBRYONIC STEM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MAPPING; HUMAN; HUMAN CELL; IL 6 GENE; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION;

CELL PROLIFERATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MESENCHYMAL STEM CELLS;

EID: 84864278141     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825940a4     Document Type: Article

References (34)

1. Koch CA, Geraldes P, Platt JL. Immunosuppression by embryonic stem cells. Stem Cells 2008; 26: 89.
2. Yen BL, Chang CJ, Liu KJ, et al. Human embryonic stem cellYderived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 2009; 27: 451.
3. Cheng EH, Chen W, Chang SY, et al. Blastocoel volume is related to successful establishment of human embryonic stem cell lines. Reprod Biomed Online 2008; 17: 436.
4. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145.
5. McIntosh K, Zvonic S, Garrett S, et al. The immunogenicity of human adipose derived cells: temporal changes in vitro. Stem Cells 2006; 24: 1246.
6. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissueYderived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118.
7. Sessarego N, Parodi A, Podestà MF, et al. Multi-potent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008; 93: 339.
8. Wolbank S, Peterbauer A, Fahrner MS, et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007; 13: 1173.
9. Oh W, Kim DS, Yang YS, et al. Immunological properties of umbilical cord blood derived mesenchymal stromal cells. Cell Immunol 2008; 251: 116.
10. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal humanmesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21: 105.
11. Wu KH, Chan CK, Tsai C, et al. Effective treatment of severe steroidresistant acute graft-versus-host disease with umbilical cordYderived mesenchymal stem cells. Transplantation 2011; 91: 1412.
12. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499.
13. Ball LM, Bernardo ME, Roelofs HA, et al. Co-transplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation. Blood 2007; 110: 2764.
14. Le Blanc K, Rasmusson I, Sundberg BC, et al. Treatment of severe acute graft-versus-host disease with third-party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439.
15. Macmillan ML, Blazar BR, DeFor TE, et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase IYII clinical trial. Bone Marrow Transplant 2009; 43: 447.
16. Inoue S, Popp FC, Koehi GE, et al. Immunomodulatory effects of mesenchymal stem cells in arat organ transplant model. Transplantation 2006; 81: 1589.
17. Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106: 1755.
18. Djouad F, Fritz V, Apparailly F, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005; 52: 1595.
19. Ninichuk V, Gross O, Segerer S, et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006; 70: 121.
20. Kunter U, Rong S, Djuric Z, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 2202.
21. Chao YH, Tsai C, Peng CT, et al. Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplant 2011; 46: 1391.
22. Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)- 6Ytype cytokine signalling and its regulation. Biochem J 2003; 374: 1.
23. Djouad F, Charbonnier LM, Bouffi C, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6 dependent mechanism. Stem Cells 2007; 25: 2025.
24. Liu CH, Hwang SM. Cytokine interaction in mesenchymal stem cells from cord blood. Cytokine 2005; 32: 270.
25. Tsai MS, Hwang SM, Chen KD, et al. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007; 25: 1511.
26. Ramasamy R, Fazekasova H, Lam EW et al. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007; 83: 71.
27. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2006; 6: e1000029.
28. Guleria I, Sayegh MH. Maternal acceptance of the fetus: true human tolerance. J Immunol 2007; 178: 3345.
29. Billingham RE, Brent L, Medawar PB. 'Actively acquired tolerance' of foreign cells. Nature 1953; 172: 603.
30. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates: prevention of allogeneic fetal rejection by tryptophan catabolism. Symp Soc Exp Biol 1953; 7: 320.
31. Sun L, Akiyama K, Zhang H, et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009; 27: 1421.
32. Chang YJ, Shih DT, Tseng CP, et al. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006; 24: 679.
33. Chao YH, Peng CT, Harn HJ, et al. Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann Hematol 2010; 89: 715.
34. Olson JA, Zeiser R, Beilhack A, et al. Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation. J Immunol 2009; 183: 3219.